| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |